Significance of trogocytosis and exosome-mediated transport in establishing and maintaining the tumor microenvironment in lymphoid malignancies

  • Kawashima Masaharu
    Department of Hematological Malignancy, Institute of Medical Science, Tokai University, Isehara, Kanagawa, Japan, Division of Clinical Oncology and Hematology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan,
  • Higuchi Hiroshi
    Department of Hematological Malignancy, Institute of Medical Science, Tokai University, Isehara, Kanagawa, Japan, Center for Cancer Immunology and Cutaneous Biology Research Center, Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
  • Kotani Ai
    Department of Hematological Malignancy, Institute of Medical Science, Tokai University, Isehara, Kanagawa, Japan,

Search this article

Abstract

<p>It is widely accepted that the tumor microenvironment plays an important role in the progression of lymphoid malignancies. Interaction between the tumor and its surrounding immune cells is considered a potential therapeutic target. For example, anti-programmed cell death 1 (PD-1) antibody stimulates the surrounding exhausted immune cells to release PD-1/PD-L1, thereby leading to the regression of PD-L1-positive tumors. Recently, biological phenomena, such as trogocytosis and exosome-mediated transport were demonstrated to be involved in establishing and maintaining the tumor microenvironment. We found that trogocytosis-mediated PD-L1/L2 transfer from tumor cells to monocytes/macrophages is involved in immune dysfunction in classic Hodgkin lymphoma. Exosomes derived from Epstein-Barr virus (EBV)-associated lymphoma cells induce lymphoma tumorigenesis by transferring the EBV-coding microRNAs from the infected cells to macrophages. In this review, we summarized these biological phenomena based on our findings.</p>

Journal

Citations (1)*help

See more

References(94)*help

See more

Related Projects

See more

Details 詳細情報について

Report a problem

Back to top